1. Home
  2. EU vs NBY Comparison

EU vs NBY Comparison

Compare EU & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo enCore Energy Corp.

EU

enCore Energy Corp.

HOLD

Current Price

$2.79

Market Cap

464.5M

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$0.71

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
EU
NBY
Founded
2009
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Sector
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
464.5M
398.2M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
EU
NBY
Price
$2.79
$0.71
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
3.7M
2.0M
Earning Date
03-02-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
$44,142,000.00
$10,302,000.00
Revenue This Year
$17.41
$23.91
Revenue Next Year
$95.45
$32.05
P/E Ratio
N/A
$29.23
Revenue Growth
N/A
390.34
52 Week Low
$1.01
$0.46
52 Week High
$4.19
$19.95

Technical Indicators

Market Signals
Indicator
EU
NBY
Relative Strength Index (RSI) 44.88 35.24
Support Level $2.60 $0.75
Resistance Level $3.13 $0.95
Average True Range (ATR) 0.26 0.52
MACD -0.08 -0.50
Stochastic Oscillator 16.67 0.13

Price Performance

Historical Comparison
EU
NBY

About EU enCore Energy Corp.

enCore Energy Corp together with its subsidiary, is engaged in the acquisition and exploration of resource properties of uranium resource properties in the United States. The holds a portfolio of uranium assets located in New Mexico, South Dakota, Wyoming, Texas, Utah, Colorado, and Arizona in the USA, and is advancing its properties with a focus on utilizing in-situ recovery. The company's Projects are South Texas Operations, Dewey-Burdock Project, Gas Hills Project, Crownpoint & Hosta Butte Project, PFN (Prompt Fission Neutron) Technology, and Other Assets.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: